Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015740
Filing Date
2024-11-14
Accepted
2024-11-14 16:40:34
Documents
105
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fbio-20240930x10q.htm   iXBRL 10-Q 4066932
2 EX-10.4 fbio-20240930xex10d4.htm EX-10.4 535534
3 EX-10.5 fbio-20240930xex10d5.htm EX-10.5 206554
4 EX-31.1 fbio-20240930xex31d1.htm EX-31.1 13885
5 EX-31.2 fbio-20240930xex31d2.htm EX-31.2 14567
6 EX-32.1 fbio-20240930xex32d1.htm EX-32.1 8190
7 EX-32.2 fbio-20240930xex32d2.htm EX-32.2 8127
  Complete submission text file 0001558370-24-015740.txt   16096621

Data Files

Seq Description Document Type Size
8 EX-101.SCH fbio-20240930.xsd EX-101.SCH 118043
9 EX-101.CAL fbio-20240930_cal.xml EX-101.CAL 91973
10 EX-101.DEF fbio-20240930_def.xml EX-101.DEF 463982
11 EX-101.LAB fbio-20240930_lab.xml EX-101.LAB 821361
12 EX-101.PRE fbio-20240930_pre.xml EX-101.PRE 677517
108 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20240930x10q_htm.xml XML 2690790
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 241463540
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)